Showing results (311-320 of 362) with videos related to

Sort By:
Pageof 37
Oncotarget|December 23, 2015
MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cellsFrancisco J Cimas, Juan L Callejas-Valera, Raquel Pascual-Serra, et al.
Nature Structural & Molecular Biology|November 29, 2011
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumorsMatilde Murga, Stefano Campaner, Andres J Lopez-Contreras, et al.
Investigative Ophthalmology & Visual Science|October 13, 2021
Influence of Sex on Neuroretinal Degeneration: Six-Month Follow-Up in Rats With Chronic GlaucomaMaria J Rodrigo, Teresa Martinez-Rincon, Manuel Subias, et al.
Pharmaceutics|February 21, 2020
The Biological Potential Hidden in Inclusion BodiesLaia Gifre-Renom, Joaquin Seras-Franzoso, Diana Rafael, et al.
Biomedicines|December 23, 2023
Differential Study of Retinal Thicknesses in the Eyes of Alzheimer's Patients, Multiple Sclerosis Patients and Healthy SubjectsElena Garcia-Martin, Daniel Jimeno-Huete, Francisco J Dongil-Moreno, et al.
Drug Delivery|July 29, 2022
Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheresAlba Aragón-Navas, María J Rodrigo, David Garcia-Herranz, et al.
Pharmaceutics|February 10, 2021
Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence TomographyMaria Jesus Rodrigo, Amaya Pérez Del Palomar, Alberto Montolío, et al.
Drug Delivery|April 11, 2025
Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucomaMiriam Ana González-Cela-Casamayor, María J Rodrigo, Marco Brugnera, et al.
Pharmaceutics|May 17, 2020
Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic FormatLaia Gifre-Renom, Estefania Ugarte-Berzal, Erik Martens, et al.
Pharmaceutics|April 28, 2023
A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain ProteinsAdrià López-Cano, Neus Ferrer-Miralles, Julieta Sánchez, et al.
Pageof 37